Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
07 2019
Historique:
received: 01 11 2018
revised: 05 03 2019
accepted: 07 03 2019
pubmed: 13 3 2019
medline: 30 7 2020
entrez: 13 3 2019
Statut: ppublish

Résumé

Fibrodysplasia ossificans progressiva (FOP) is a rare, autosomal dominant disorder characterized by heterotopic ossification (HO) in muscles, ligaments and tendons. Flare-ups often precede the formation of HO, resulting in immobilization of joints. Due to progression of the disease without signs of a flare-up, co-existence of a chronic progression of HO has been postulated, but conclusive evidence is lacking. Recently, it has been shown that [

Identifiants

pubmed: 30858149
pii: S8756-3282(19)30085-7
doi: 10.1016/j.bone.2019.03.009
pii:
doi:

Substances chimiques

Sodium Fluoride 8ZYQ1474W7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Esmée Botman (E)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine Section Endocrinology, Amsterdam Bone Center, Amsterdam Movement Sciences, the Netherlands.

Pieter G H M Raijmakers (PGHM)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology & Nuclear Medicine, the Netherlands.

Maqsood Yaqub (M)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology & Nuclear Medicine, the Netherlands.

Bernd Teunissen (B)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology & Nuclear Medicine, the Netherlands.

Coen Netelenbos (C)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine Section Endocrinology, Amsterdam Bone Center, Amsterdam Movement Sciences, the Netherlands.

Wouter Lubbers (W)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anaesthesiology, the Netherlands.

Lothar A Schwarte (LA)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anaesthesiology, the Netherlands.

Dimitra Micha (D)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Genetics, Amsterdam Bone Center, Amsterdam Movement Sciences, the Netherlands.

Nathalie Bravenboer (N)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Chemistry, Amsterdam Bone Center, Amsterdam Movement Sciences, the Netherlands.

Ton Schoenmaker (T)

Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit.

Teun J de Vries (TJ)

Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit.

Gerard Pals (G)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Genetics, Amsterdam Bone Center, Amsterdam Movement Sciences, the Netherlands.

Jan Maerten Smit (JM)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Plastic, Reconstructive and Hand Surgery, Amsterdam Bone Center, the Netherlands.

Pieter Koolwijk (P)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, the Netherlands.

Dinko González Trotter (DG)

Regeneron Pharmaceuticals, Inc., New York, United States of America.

Adriaan A Lammertsma (AA)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology & Nuclear Medicine, the Netherlands.

E Marelise W Eekhoff (EMW)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine Section Endocrinology, Amsterdam Bone Center, Amsterdam Movement Sciences, the Netherlands. Electronic address: emw.eekhoff@vumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH